GABA function in mood disorders: An update and critical review

Life Sciences

Volumn 63, Issue 15, 1998, Pages 1289-1303

  Shiah, I Shin ^a,b   Yatham, Lakshmi N ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Antidepressants; Depression; Electroconvulsive therapy; GABA; GABA(B) receptors; Mania; Mood stabilizers; Receptors

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; BENZODIAZEPINE; CARBAMAZEPINE; CARBON 14; CLONAZEPAM; DESIPRAMINE; FLUMAZENIL; FLUOXETINE; GABAPENTIN; IMIPRAMINE; LITHIUM; MIANSERIN; PHENELZINE; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; ZIMELDINE;

DEPRESSION; ELECTROCONVULSIVE THERAPY; GABAERGIC TRANSMISSION; HUMAN; MANIA; MENTAL DISEASE; MOOD; NEUROTRANSMISSION; NONHUMAN; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; REVIEW;

EID: 0032483234     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00241-0     Document Type: Short Survey

References (137)

1. 1. R.G. PAREDES and A. AGMO, Neurosci. Biobehav. Rev. 16 145-170 (1992).
2. 2. W. HAEFELY, The Role of GABA in Anxiolytic/Antidepressant Drug Action, M. Martin Elliott, D.J. Heal and C.A. Marsden (Eds), 151-168, John Wiley & Sons, New York (1992).
3. 3. D.R. HILL and N.G. BOWERY, Nature 290 149-152 (1981).
4. 4. R.R. MATSUMOTO, Brain Res. Rev. 14 203-225 (1989).
5. 5. H.M. EMRICH, D.V. ZERSSEN, W. KISSLING, H.J. MOLLER and A. WINDORFER, Arch. Psychiatr. Nervenkr. 229 1-16 (1980).
6. 6. W.H. BERRETTINI and R.M. POST, GABA in Affective Illnesses, R.M. Post and J.C. Ballenger (Eds), 673-685, William & Wilkins, Baltimore (1984).
7. 7. G. BARTHOLINI, K.G. LLOYD, B. SCATTON, B. ZIVKOVIC and P.L. MORSELLI, Psychopharmacol. Bull. 21 385-388 (1985).
8. 8. K.G. LLOYD, GABA and Depression, N.G. Bowery and G. Nistico (Eds), 301-343, Pythagora Press, Rome-Milan (1989).
9. 9. K.G. LLOYD, B. ZIVKOVIC, B. SCATTON, P.L. MORSELLI and G. BARTHOLINI, Prog. Neuropsychopharmacol. Biol. Psychiatr. 13 341-351 (1989).
10. 10. F. PETTY, G.L. KRAMER and W. HENDRICKSE, GABA and Depression, J.J. Mann and D.J. Kupfer (Eds), 79-108, Plenum Press, New York (1993).
11. 11. F. PETTY, J. Affect. Disord. 34 275-281 (1995).
12. 12. M.E.P. SELIGMAN and S.F. MAIER, J. Exp. Psychol. 74 1-9 (1967).
13. 13. F. PETTY and A.D. SHERMAN, Pharmacol. Biochem. Behav. 156 567-570 (1981).
14. 14. A.D. SHERMAN and F. PETTY, Behav. Neural. Biol. 35 344-353 (1982).
15. 15. A.D. SHERMAN and F. PETTY, BEHAV. Neural. Biol. 30 119-134 (1980).
16. 16. K.G. LLYOD, P.L. MORSELLI, H. DEPOORTERE, V. FOURNIER, B. ZIVKOVIC, B. SCATTON, C. BROEKKAMP, P. WORMS and G. BARTHOLINI, Pharmacol. Biochem. Behav. 18 957-966 (1983).
17. 17. M. PONCELET, P. MARTIN, S. DANTI, P. SIMON and P. SOUBRIE, Pharmacol. Biochem. Behav. 28 321-326 (1987).
18. 18. P. MARTIN, P. PICHAT, J. MASSOL, P. SOURBRIE, K.G. LLOYD and A.J. PUECH, Neuropsychobiology 22 220-224 (1989).
19. 19. S. JANCSAR and B.E. LEONARD, Prog. Neuropsychopharmacol. Biol. Psychiatr. 8 263-269 (1984).
20. 20. K.G. LLOYD and P. PICHAT, Br. J. Pharmacol. 87 36P (1985).
21. 21. T. DENNIS, V. BEAUCHEMIN and N. LAVOIE, Pharmacol. Biochem. Behav. 46 77-82 (1993).
22. 22. B.E. LEONARD and M. TUITE, Int. Rev. Neurobiol. 22 251-286 (1981).
23. 23. B.I. GOLD, M.B. BOWER, R.H. ROTH and D.W. SWEENEY, Am. J. Psychiatry 137 362-364 (1980).
24. 24. R.H. GERNER and T.A. HARE, Am. J. Psychiatry 138 1098-1101 (1981).
25. 25. R.H. GERNER, L. FAIRBANKS, G.M. ANDERSON, J.G. YOUNG, M. SCHEININ, M. LINNOILA, T.A. HARE, B.A. SHAYWITZ and D.J. COHEN, Am. J. Psychiatry 141 1533-1540 (1984).
26. 26. K. KASA, S. OTSUKI, M. YAMAMOTO, M. SATO, H. KURODA and N. OGAWA, Biol. Psychiatry 17 877-883 (1982).
27. 27. R. ZIMMER, A.W. TEELKEN, K.D. MEIER, M. ACKENHEIL and K.J. ZANDER, Prog. Neuropsychopharmacol. Biol. Psychiatr. 4 613-620 (1981).
28. 28. R.M. POST, J.C. BALLENGER, T.A. HARE, F.K. GOODWIN, C.R. LAKE, D.C. JIMERSON and W.E. BUNNERY, Brain Res. Bull. 5 (Suppl. 2) 755-759 (1980).
29. 29. R.T. JOFFE, R.M. POST, D.R. RUBINOW, W.H. BERRETTINI, T.A. HARE, J.C. BALLENGER and P.P. ROY-BYRNE, Cerebrospinal Fluid GABA in Manic-Depressive Illness, G. Bartholini, K.G. Lloyd and P.L. Morselli (Eds), 187-193, Raven Press, New York (1986).
30. 30. A. ROY, J. DEJONG and T. FERRARO, Psychol. Med. 21 613-618 (1991).
31. 31. W. BERRETTINI, J.I. NURNBERGER, T.A. HARE, S. SIMMONS-ALLING, E.S. GERSHON and R.M. POST, Biol. Psychiatry 18 185-194 (1983).
32. 32. W.H. BERRETTINI, J.I. NURNBERGER, T.A. HARE, S. SIMMONS-ALLING and E.S. GERSHON, Biol. Psychiatry 21 844-846 (1986).
33. 33. A. HONIG, J.R. BARTLETT, N. BOURAS and P.K. BRIDGES, J. Psychiatr. Res. 22 159-164 (1988).
34. 34. F. PETTY, Clin. Chem. 40 296-302 (1994).
35. 35. W. LOSCHER and D. SCHMIDT, Ther. Drug Monit. 6 227-231 (1984).
36. 36. W. LOSCHER, J. Neurochem. 38 293-295 (1979).
37. 37. J.W. FERKANY, I.J. BUTLER and S.J. ENNA, J. Neurochem. 33 29-33 (1978).
38. 38. P. BOHELN, S. HUOT and M.G. PALFREYMAN, Brain Res. 167 297-305 (1979).
39. 39. W. LOSCHER, J Neurochem. 38 293-295 (1982).
40. 40. V.S. UHLHAAS, H. LANAGE, J. WAPPENSCHMIDT and K. OLEK, Acta. Neurol. Scand. 74 261-265 (1986).
41. 41. W.H. BERRETTINI, J.I. NURNBERGER, T. HARE, E.S. GERSHON and R.M. POST, Br. J. Psychiatry 141 483-487 (1982).
42. 42. D. SCHMIDT and W. LOSCHER, J. Neurol. Neurosurg. Psychiatry 45 931-935 (1982).
43. 43. F. PETTY and M.A. SCHLESSER, J. Affect. Disord. 3 339-343 (1981).
44. 44. F. PETTY and A.D. SHERMAN, J. Affect. Disord. 6 131-138 (1984).
45. 45. F. PETTY, G.L. KRAMER, C.H. GULLION and A.J. RUSH, Biol. Psychiatry 32 354-363 (1992).
46. 46. A. RODE, A. BIDZINSKI and S. PUZYNSKI, Psychiatr. Pol. 25 4-7 (1991).
47. 47. F. PETTY, G.L. KRAMER, M. FULTON, L. DAVIS and J.A. RUSH, Biol. Psychiatry 37 806-810 (1995).
48. 48. F. PETTY, G.L. KRAMER, M. FULTON, F.G. MOELLER and A.J. RUSH, Neuropsychopharmacology 9 125-132 (1993).
49. 49. H. KAIYA, M. NAMBA, H. YOSHIDA and S. NAKAMURA, Psychiatr. Res. 6 335-343 (1982).
50. 50. W.H. BERRETTINI, B. UMBERKOMAN-WIITA, J.I. NURNBERGER, W.H. VOGEL, E.S. GERSHON and R.M. POST, Psychiatr. Res. 7 255-260 (1982).
51. 51. E.K. PERRY, P.H. GIBSON, G. BLESSES, R.H. PERRY and B.E. TOMLINSON, J. Neurol. Sci. 34 247-265 (1977).
52. 52. S.C. CHEETHAM, M.R. CROMPTON, C.L.E. KATONA, S.J. PARKER and R.W. HORTON, Brain Res. 460 114-123 (1988).
53. 53. E.R. KORPI, J.E. KLEINMAN and R.J. WYATT, Biol. Psychiatry 23 109-114 (1988).
54. 54. G.M. STOCKS, S.C. CHEETHAM, M.R. CROMPTON, C.L.E. KATONA and R.W. HORTON, J. Affect. Disord. 18 11-15 (1990).
55. 55. J.A. CROSS, S.C. CHEETHAM, M.R. CROMPTON, C.L.A.E. KATONA and R.W. HORTON, Psychiatr. Res. 26 119-129 (1988).
56. 56. B. ARRANZ, R. COWBURN, A. ERIKSSON, M. VESTLING and J. MARCUSSON, Neuropsychobiology 26 33-36 (1992).
57. 57. R. GAMSE, D.E. VACCARO, G. GAMSE, M. DIPACE, T.O. FOX and S.E. LEEMAN, Proc. Natl. Acad. Sci. U.S.A. 77 5552-5556 (1980).
58. 58. E.E. MULLER, Physiol. Rev. 67 962-1053 (1987).
59. 59. M. KOULU, R. LAMMINTAUSTA and S. DAHLSTROM, J. Clin. Endocrinol. Metab. 48 1038-1040 (1979).
60. 60. C. MARCHESI, P. CHIODERA, A. DE FERRI, C. DE RISIO, L. DASSO, P. MENOZZI, R. VOLPI and V. COIRO, Psychoneuroendocrinology 16 475-479 (1991).
61. 61. K. O'FLYNN and T.G. DINAN, Am. J. Psychiatry 150 1728-1730 (1993).
62. 62. P. MONTELEONE, M. MAJ, M. IOVINO and L. STEARDO, J. Affect. Disord. 20 1-5 (1990).
63. 63. L.L. DAVIS, M. TRIVEDI, A. CHOATE, G.L. KRAMER and F. PETTY, Psychoneuroendocrinology 22 129-140 (1997).
64. 64. V. KUSUMAKAR, L.N. YATHAM, D.R.S. HASLAM, S.V. PARIKH, R. MATTE, P.H. SILVERSTONE and V. SHARMA, Can. J. Psychiatry 42 (Suppl 2) 79S-86S (1997).
65. 65. L.N. YATHAM, V. KUSUMAKAR, S.V. PARIKH, D.R.S. HASLAM, R. MATTE, V. SHARMA and S. KENNEDY, Can. J. Psychiatry 42 (Suppl 2) 87S-91S (1997).
66. 66. R. BERNASCONI, The GABA Hypothesis of Affective Illness: Influence of Clinically Effective Antimanic Drugs on GABA Turnover, H.M. Emrich, H.D. Aldenhoff and H.D. Lux (Eds), 183-191, Excerpta Medica, Amsterdam (1982).
67. 67. R.M. POST, S.R.B. WEISS and D.M. CHUANG, J. Clin. Psychopharmacol. 12 23S-35S (1992).
68. 68. K.G. LLOYD, F. THURET and A. PILC, J. Pharmacol. Exp. Ther. 235 191-199 (1985).
69. 69. N. MOTOHASHI, K. IKAWA and T. KARIYA, Eur. J. Pharmacol. 166 95-99 (1989).
70. 70. N. MOTOHASHI, Prog. Neuropsychopharmacol. Biol. Psychiatry 16 571-579 (1992).
71. 71. A. MAGGI and S.J. ENNA, J. Neurochem. 34 888-892 (1980).
72. 72. F. PETTY, A.J. RUSH, J.M. DAVIS, J.R. CALABRESE, S.E. KIMMEL, G.L. KRAMER, J.G. SMALL, M.J. MILLER, A.E. SWANN, P.J. ORSULAK, M.E. BLAKE and C.L. BOWDEN, Biol. Psychiatry 39 278-284 (1996).
73. 73. R.M. POST, T.W. UHDE and J.C. BALLENGER, Efficacy of Carbamazepine in Affective Disorders: Implications for Underlying Physiological and Biochemical Substrates, H.M. Emrich, T. Okuma and A.A. Muller (Eds), 93-115, Elsevier Science Publishers, Amsterdam (1984).
74. 74. R. ZIMMER, A.W. TEELKEN, M. GUNDUREWA, E. RUTHER and H. CRAMER, Brain Res. Bull. 5 (Suppl 2) 585-588 (1980).
75. 75. A. LAUTIN, B. ANGRIST, M. STANLEY, S. GERSHON, K. HECKL and M. KAROBATH, Br. J. Psychiatry 137 240-244 (1980).
76. 76. W. LOSCHER and H. SIEMES, Epilepsia 26 314-319 (1985).
77. 77. W. LOSCHER and D. SCHMIDT, Life Sci. 28 283-288 (1981).
78. 78. M. LOSCHER and D. SCHMIDT, Epilepsia 21 611-615 (1980).
79. 79. M.C. PREVETT, A.A. LAMMERTSMA, D.J. BROOKS, P.A. BARTENSTEIN, P.N. PATSALOS, D.R. FISH and J.S. DUNCAN, Epilepsia 36 113-121 (1995).
80. 80. R.A. KOEPPE, V.A. HOLTHOFF, K.A. FREY, M.R. KILBOURN and D.E. KUHL, J. Cereb. Blood Flow Metab. 11 735-744 (1991).
81. 81. I-S. SHIAH, L.N. YATHAM, R.W. LAM and A.P. ZIS, Neuropsychopharmacology 17 382-390 (1997).
82. 82. A. PILC and K.G. LLOYD, Life Sci. 35 2149-2154 (1984).
83. 83. P.D. SUZADAK and F. GIANUTSOS, Neuropharmacology 24 217-222 (1985).
84. 84. B.E. SURANYI-CADOTTE, T.V. DAM and R. QUIRION, Eur. J. Pharmacol. 106 673-675 (1984).
85. 85. M.L. BARBACCIA, L. RAVIZZA and E. COSTA, J. Pharmacol. Exp. Ther. 236 307-312 (1986).
86. 86. K.G. LLOYD and P. PICHAT, GABA Synapses, Depression and Antidepressant Drugs, S.G. Dahl, S.M.P. Gram and W.Z. Potter (Eds), 113-126, Springer-Verlag, Berlin (1987).
87. 87. G.D. PRATT and N.G. BOWERY, Br. J. Pharmacol. 110 724-735 (1993).
88. 88. A.M. SZEKELY, M.L. BARBACCIA and E. COSTA, J. Pharmacol. Exp. Ther. 243 155-159 (1987).
89. 89. J.A. CROSS and R.W. HORTON, Eur. J. Pharmacol. 141 159-162 (1987).
90. 90. J.A. CROSS and R.W. HORTON, Br. J. Pharmacol. 93 331-336 (1988).
91. 91. D.J. MCMANUS and A.J. GREENSHAW, Biochem. Pharmacol. 42 1525-1528 (1991).
92. 92. A.H. ENGELBRECHT, V.A. RUSSELL and J.J.F. TALJAARD, Neurochem. Res. 9. 1119-1123 (1994).
93. 93. J.A. GRAY, G.M. GOODWIN, D.J. HEAL and A.R. GREEN, Br. J. Pharmacol. 92 863-870 (1987).
94. 94. J.A. GRAY and R.A. GREEN, Br. J. Pharmacol. 92 357-362 (1987).
95. 95. F. BORSINI, S. GIULIANI and A. MELI, J. Pharm. Pharmacol. 38 934-935 (1986).
96. 96. N.G. BOWERY, D.R. HILL, A.L. HUDSON, A. DOBLE, D.N. MIDDLEMISS, J. SHAW and M. TURNBULL, Nature 283 92-94 (1980).
97. 97. G. BARTHOLINI, B. SCATTON, B. ZIVKOVIC, K.G. LLOYD, H. DEPOORTERE, S.Z. LANGER and P.L. MORSELLI, GABA Receptor Agonists as a New Therapeutic Class, G. Bartholini, L. Bossi, K.G. Lloyd and P.L. Morselli (Eds), 1-30, Raven Press, New York (1985).
98. 98. D.J. MCMANUS and A.J. GREENSHAW, Psychopharmacology 103 204-208 (1991).
99. 99. D. JOLY, K.G. LLOYD, P. PICHAT and D.J. SANGER, Br. J. Pharmacol. 90 125P (1987).
100. 100. Y. NAKAGAWA, T. ISHIMA, Y. ISHIBASHI, M. TSUJI and T. TAKASHIMA, Brain Res. 741 240-245 (1996).
101. 101. P. MONTELEONE, L. STEARDO, C. TANZILLO and M. MAJ, J. Neural Transm. 82 147-152 (1990).
102. 102. F. PETTY, J. STEINBERG, G.L. KRAMER, M. FULTON and F.G. MOELLER, J. Affect. Disord. 29 53-56 (1993).
103. 103. M. WIELOSZ, M. STELMASIAK, G. OSSOWSKA and Z. KLINROCK, Pol. J. Pharmacol. Pharm. 37 113-122 (1985).
104. 104. A.R. GREEN, A. METZ, M.C.W. MINCHIN and N.D. VINCENT, Br. J. Pharmacol. 92 5-11 (1987).
105. 105. A. STELZER, R. LAAS and A. FLEISSNER, J. Neural Transm. 62 99-106 (1985).
106. 106. A.R. GREEN, E. PERALTA, J.S. HONG, C.C. MAO, C.K. ATTERWILL and E. COSTA, Br. J. Pharmacol. 92 13-18 (1978).
107. 107. J.F.W. DEAKIN, F. OWEN, A.J. CROSS and M.J. DASHWOOD, Psychopharmacology 73 345-349 (1981).
108. 108. J.M. BOWDLER, A.R. GREEN, M.C.W. MINCHIN and D.J. NUTT, J. Neural Transm. 56 3-12 (1983).
109. 109. A.R. GREEN and N.D. VINCENT, Br. J. Pharmacol. 92 19-24 (1987).
110. 110. D.P. DEVANAND, B. SHAPIRA, F. PETTY, L. FITZSIMONS, B. LERER and H.A. SACKEIM, Convulsive Ther. 11 3-13 (1995).
111. 111. A.R. GREEN and D.J. NUTT, Antidepressants, D.G. Grahame-Smith and P.J. Lowen (Eds), Excerpta Mediea, Amsterdam (1983).
112. 112. B.E. LEONARD, Effect of Antidepressants on Specific Neurotransmitters: Are Such Effects Relevant to the Therapeutic Action? J.A. den Boer and J.M. Ad Sitsen (Eds), 379-404, Marcel Dekker, Inc., New York (1994).
113. 113. A.M. FRANCOIS-BELLAN, M. HERY, M. FALDON and F. HERY, Neurochem. Int. 134 455-462 (1988).
114. 114. A.R. GREEN, P. JOHNSON, J.A. MOUNTFORD and V.L. NIMGAONKAR, Br J Pharmacol 84 337-346 (1985).
115. 115. J.A. GRAY, A. METZ, G.M. GOODWIN and A.R. GREEN, Neuropharmacology 25 711-716 (1986).
116. 116. A. METZ, G.M. GOODWIN and A.R. GREEN, Neuropharmacology 24 357-360 (1985).
117. 117. G. BONANNO and M. RAITERI, J. Neural Transm. 69 59-70 (1987).
118. 118. G. BONANNO and M. RAITERI, Synapse 1 254-257 (1987).
119. 119. B. SCATTON, K.G. LLOYD, B. ZIVKOVIC, T. DENNIS, Y. CLAUSTRE, J. DEDEK, S. ARBILLA, S.Z. LANGER and G. BARTHOLINI, J. Pharmacol. Exp. Ther. 241 251-257 (1987).
120. 120. E.W. KARBON and S.J. ENNA, Neurosci. Abstr. 13 55 (1983).
121. 121. F. PETTY, M.H. TRIVEDI, M. FULTON and J.A. RUSH, Biol. Psychiatry 38 578-591 (1995).
122. 122. G. CHOUINARD, S.N. YOUNG and L. ANNABLE, Biol. Psychiatry 18 451-466 (1983).
123. 123. B.S. VICTOR, N.A. LINK, R.L. BINDER and I.R. BELL, Am. J. Psychiatry 141 1111-1112 (1984).
124. 124. J.P. FREINHAR and W.A. ALVAREZ, J. Clin. Psychiatry 46 29-30 (1985).
125. 125. L.W. ADLER, J. Clin. Psychiatry 47 49-50 (1986).
126. 126. A.C. PANDE, Psychosomatics 29 333-335 (1988).
127. 127. T. BOTTAI, B. HUE, D. HILLAIRE-BUYS, A. BARBE, R. ALRIC, R. POUGET and P. PETIT, J. Affect. Disord. 36 21-27 (1995).
128. 128. R. EDWARDS, U. STEPHENSON and T. FLEWETT, Aust. N.Z. J. Psychiatry 25 238-242 (1991).
129. 129. U.S. GABAPENTIN STUDY GROUP, Epilepsy Res. 18 67-73 (1994).
130. 130. M.J. MCLEAN, Epilepsia 36 (Suppl. 5) S73-S86 (1995).
131. 131. D.B. MARCOTTE, L. FOGLEMAN, N. WOLFE and R. NEMIRE, 150th Annual Meeting of the American Psychiatric Association New Research Program & Abstracts, Abstract NR261, 138, San Diego (1997).
132. 132. M.A. FRYE, T.A. KETTER, T. KIMBRELL, G. CORA-LOCATELLI, R.T. DUNN and R.M. POST, 150th Annual Meeting of the American Psychiatric Association Syllabus & Proceedings Summary, Symposium 33C, 85, San Diego (1997).
133. 133. S.L. MCELROY, C.A. SOUTULLO, P.E. KECK and G.F. KMETZ, Ann. Clin. Psychiatry 9 99 (1997).
134. 134. R.S. RYBACK, L. BRODSKY and F. MUNASIFI, J. Neuropsychiatry Clin. Neurosci. 9 301 (1997).
135. 135. C.B. SCHAFFER and L.C. SCHAFFER, Am. J. Psychiatry 154 291-292 (1997).
136. 136. L.T. YOUNG, J.C. ROBB, I. PATELIS-SIOTIS, C. MACDONALD and R.T. JOFFE, Biol. Psychiatry 42 851-853 (1997).
137. 137. O.A. PETROFF, D.L. ROTHMAN, K.L. BEHAR, D. LAMOUREUX and R.H. MATTSON, Ann. Neurol. 39 95-99 (1996).